TY - JOUR
T1 - Effect of Lactobacillus Plantarum IS-10506 on Paneth Cell Regeneration in the Ileum of Sprague Dawley Rats
AU - Hutama, Rasio Putra
AU - Athiyyah, Alpha Fardah
AU - Ranuh, I. G.M.Reza Gunadi
AU - Darma, Andy
AU - Sumitro, Khadijah Rizky
AU - Riawan, Wibi
AU - Surono, Ingrid S.
AU - Sudarmo, Subijanto Marto
N1 - Publisher Copyright:
© 2023 Phcogj.Com.
PY - 2023
Y1 - 2023
N2 - Background: Pathogenic Escherichia coli (E. coli) is the most common infectious agent among children in developing countries. Indigenous probiotics are not widely used to treat diarrhea and intestinal infections. This study aims to investigate the cell regeneration process of paneth cells after administration of Lactobacillus plantarum IS-10506 due to damage caused by Lipopolysaccharide (LPS) E. coli O55:B5, through the expression of MATH-1 and DEFA-6. Methods: This study used 64 paraffin blocks from Rattus norvegicus strain Sprague-Dawley divided into four groups. There were three treatments, KN, KL, KP and KPR groups, The KN group represent the administration of placebo. The KL group received LPS E. coli O55:B5 on day one. The KP group received LPS E. coli O55:B5 on the first day and Lactobacillus plantarum IS-10506 on the second day until six-day. The KPR group were administered Lactobacillus plantarum IS-10506 six days prior to receiving LPS E. coli O55:B5, respectively. All groups, except KN, received LPS at a dose of 250 μg/kg body weight once, and Lactobacillus plantarum IS-10506 at a dose of 2.86x1010 CFU/ day. Evaluating paneth cell regeneration, DEFA-6, and MATH-1 expression immunohistochemistry was conducted on all tissues. Results: The expression of DEFA-6 and MATH-1 in the KP and KPR groups on day three of observation was significantly higher from the KL group. Even though the KL group achieved significant growth, the results of this expansion were significantly smaller than KP and KPR groups. Conclusion: After mucosal injury caused by LPS E. coli O55:B5, administration of probiotic Lactobacillus plantarum IS-10506 may increase paneth cell regeneration through differentiation and cell number.
AB - Background: Pathogenic Escherichia coli (E. coli) is the most common infectious agent among children in developing countries. Indigenous probiotics are not widely used to treat diarrhea and intestinal infections. This study aims to investigate the cell regeneration process of paneth cells after administration of Lactobacillus plantarum IS-10506 due to damage caused by Lipopolysaccharide (LPS) E. coli O55:B5, through the expression of MATH-1 and DEFA-6. Methods: This study used 64 paraffin blocks from Rattus norvegicus strain Sprague-Dawley divided into four groups. There were three treatments, KN, KL, KP and KPR groups, The KN group represent the administration of placebo. The KL group received LPS E. coli O55:B5 on day one. The KP group received LPS E. coli O55:B5 on the first day and Lactobacillus plantarum IS-10506 on the second day until six-day. The KPR group were administered Lactobacillus plantarum IS-10506 six days prior to receiving LPS E. coli O55:B5, respectively. All groups, except KN, received LPS at a dose of 250 μg/kg body weight once, and Lactobacillus plantarum IS-10506 at a dose of 2.86x1010 CFU/ day. Evaluating paneth cell regeneration, DEFA-6, and MATH-1 expression immunohistochemistry was conducted on all tissues. Results: The expression of DEFA-6 and MATH-1 in the KP and KPR groups on day three of observation was significantly higher from the KL group. Even though the KL group achieved significant growth, the results of this expansion were significantly smaller than KP and KPR groups. Conclusion: After mucosal injury caused by LPS E. coli O55:B5, administration of probiotic Lactobacillus plantarum IS-10506 may increase paneth cell regeneration through differentiation and cell number.
KW - DEFA-6
KW - Escherichia coli O55:B5
KW - Lactobacillus plantarum IS-10506
KW - Lipopolysaccharide
KW - MATH-1
KW - Paneth cells
UR - http://www.scopus.com/inward/record.url?scp=85183713761&partnerID=8YFLogxK
U2 - 10.5530/pj.2023.15.177
DO - 10.5530/pj.2023.15.177
M3 - Article
AN - SCOPUS:85183713761
SN - 0975-3575
VL - 15
SP - 928
EP - 932
JO - Pharmacognosy Journal
JF - Pharmacognosy Journal
IS - 5
ER -